Category: Latest News
-
Elbit Systems shares jump after strong Q4 earnings beat
Elbit Systems Ltd. (NASDAQ:ESLT) reported fourth-quarter results on Tuesday that exceeded analyst expectations, sending the defense technology company’s shares higher. Adjusted earnings per share came in at $3.56, well above the consensus forecast of $2.70, representing a surprise of $0.86. Quarterly revenue totaled $2.15 billion, beating analysts’ estimate of $2.09 billion and marking an 11.3%…
-
Li Auto shares slip in pre-market after Goldman Sachs downgrade and margin concerns
Shares of Li Auto (NASDAQ:LI) fell in pre-market trading Tuesday after Goldman Sachs lowered its rating on the company from “buy” to “neutral,” following the electric vehicle maker’s fourth-quarter 2025 results. The brokerage cited increasing losses and weaker outlooks for both sales volumes and margins as key reasons for the downgrade. Goldman Sachs also reduced…
-
Oil rises more than 2%, Brent stays above $100 amid Iran supply concerns
Oil prices climbed strongly in Asian trading on Tuesday, with Brent crude holding above the $100-per-barrel level as markets continued to assess potential supply disruptions linked to the ongoing U.S.-Israel conflict with Iran. Crude benchmarks rebounded after falling about 5% in the previous session, following reports that some vessels had managed to navigate the Strait…
-
Bank of America Repriced Almonty: Lewis Black Tells All
Lewis Black discusses Bank of America’s recent Buy rating and $20 price target and provides a critical update on the Sangdong project Lyndsay Malchuk on Market Frontlines with an exclusive, no-nonsense interview with Lewis Black, CEO of Almonty Industries. In this candid conversation, Lewis reacts to the recent Bank of America initiation with a Buy…
-
One of the best silver intercepts in the world year to date
Hello, I’m Ricki Lee, and this is The Capital Compass. Today we’re speaking with Group Eleven Resources (TSXV:ZNG) (USOTC:GRLVF)— a company undergoing a strategic shift. Long known for its zinc exploration success in Ireland, Group Eleven is now increasingly being recognized for something else: silver. Recent drill results have delivered one of the best silver…
-
Gold rises back above $5,000 as Iran conflict and central bank meetings dominate market focus
Gold prices moved higher during Asian trading on Tuesday, climbing back above key levels as investors monitored developments in the U.S.-Israel conflict with Iran, fluctuations in oil prices and a series of central bank policy meetings scheduled for this week. The precious metal had briefly slipped below the $5,000-per-ounce mark in the previous session. However,…
-
Futures slip as oil rises, RBA hikes rates and Nvidia outlines massive AI sales outlook: Dow Jones, S&P, Nasdaq, Wall Street
U.S. stock futures pointed lower on Tuesday as investors weighed geopolitical tensions around Iran and disruptions to global energy supply. Oil prices climbed following fresh security incidents near the Strait of Hormuz, while gold edged higher ahead of a key Federal Reserve meeting later this week. Meanwhile, the Reserve Bank of Australia increased interest rates…
-
Why industrial gases are the gold of the digital age
Part 3 of a 3-part investor series In the first two installments of this series, we explored how U.S. Energy Corp. (NASDAQ:USEG) has evolved from a traditional E&P company into an emerging industrial gas and carbon management platform — and how its 2026 plan sets the foundation for multi‑stream, long‑duration value creation. Part 3 zooms out. Because…
-
Sharp Pullback By Oil Prices Sparks Rebound On Wall Street
After moving notably lower over the past few sessions, stocks showed a strong move back to the upside during trading on Monday. The major averages all moved notably higher, with the tech-heavy Nasdaq leading the way. The major averages ended the day off their highs of the session but still sharply higher. The Nasdaq surged…
-
CytomX highlights clinical progress for lead cancer drug in Q4 update
CytomX Therapeutics Inc. (NASDAQ:CTMX) used its fourth-quarter 2025 earnings call to highlight progress in the clinical development of its lead drug candidate, Varseta-M, while outlining its broader strategy for future growth. Although the company did not disclose detailed financial results during the call, investors reacted positively to the update, sending the stock sharply higher in…